Advanced Health Intelligence Overview
Valuation check: AHI's ROE is -7.12%, below the Technology sector average of 47.22%.
Get informed when a big investor buys or sells
+ Follow-711.80%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Advanced Health Intelligence (AHI) currently reports a ROE of -7.12%. That is below the Technology sector average of 47.22%. Use the charts on this page to explore Advanced Health Intelligence's ROE history and peer comparisons.
Advanced Health Intelligence's ROE of -7.12% is lower than the Technology sector average of 47.22%. That is roughly 1607.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Advanced Health Intelligence's current -7.12% should be judged against Technology norms (sector average: 47.22%) and against AHI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -7.12%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 47.22%. From there, open related valuation or income-statement pages for Advanced Health Intelligence, and consider following AHI for alerts when major investors trade the stock.
Advanced Health Intelligence is classified in the Technology sector. On ROE, it currently shows -7.12% versus a sector average near 47.22%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing AHI with unrelated industries.
